Found: 7
Select item for more details and to access through your institution.
The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells.
- Published in:
- Journal of Amino Acids, 2013, p. 1, doi. 10.1155/2013/251398
- By:
- Publication type:
- Article
HT-29 and Caco-2 Reporter Cell Lines for Functional Studies of Nuclear Factor Kappa B Activation.
- Published in:
- Mediators of Inflammation, 2015, v. 2015, p. 1, doi. 10.1155/2015/860534
- By:
- Publication type:
- Article
Comparative analysis reveals amino acids critical for anticancer activity of peptide CIGB-552.
- Published in:
- Journal of Peptide Science, 2016, v. 22, n. 11/12, p. 711, doi. 10.1002/psc.2934
- By:
- Publication type:
- Article
Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB-552 in mouse models.
- Published in:
- Journal of Peptide Science, 2014, v. 20, n. 11, p. 850, doi. 10.1002/psc.2676
- By:
- Publication type:
- Article
Efecto de la terapia mínimamente invasiva con surfactante versus tratamiento placebo sobre la muerte o displasia broncopulmonar en recién nacidos prematuros con síndrome de dificultad respiratoria. Ensayo clínico aleatorizado OPTIMIST-A.
- Published in:
- Enfermería Neonatal, 2022, v. 14, n. 40, p. 41
- By:
- Publication type:
- Article
The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1.
- Published in:
- Molecules, 2021, v. 26, n. 1, p. 152, doi. 10.3390/molecules26010152
- By:
- Publication type:
- Article
Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity.
- Published in:
- Molecules, 2018, v. 23, n. 4, p. 801, doi. 10.3390/molecules23040801
- By:
- Publication type:
- Article